Intravenous route of cell delivery for treatment of neurological disorders: A meta-analysis of preclinical results

Stem Cells and Development

Volumn 19, Issue 1, 2010, Pages 5-16

  Janowski, Miroslaw ^a,b   Walczak, Piotr ^c   Date, Isao ^d  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d OKAYAMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS; ARTICLE; CELL FUNCTION; CELL HETEROGENEITY; CELL THERAPY; DEPENDENT VARIABLE; EFFECT SIZE; HUMAN; INDEPENDENT VARIABLE; INTRAVENOUS CELL THERAPY; MEDLINE; MOLECULAR THERAPY; MORPHOLOGY; NEUROLOGIC DISEASE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; TREATMENT OUTCOME; VARIANCE;

ANIMALS; CELL TRANSPLANTATION; HUMANS; INFUSIONS, INTRAVENOUS; MODELS, ANIMAL; NERVOUS SYSTEM DISEASES; TISSUE THERAPY; TREATMENT OUTCOME;

ANIMALIA;

EID: 75749146977     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2009.0271     Document Type: Article

References (44)

1. Liu YP, BT Lang, MK Baskaya, RJ Dempsey and R Vemuganti. (2009). The potential of neural stem cells to repair strokeinduced brain damage. Acta Neuropathol 117:469-480.
2. Torrente Y and E Polli. (2008). Mesenchymal stem cell transplantation for neurodegenerative diseases. Cell Transplant 17:1103-1113.
3. Guzman R, R Choi, A Gera, A De Los Angeles, RH Andres and GK Steinberg. (2008). Intravascular cell replacement therapy for stroke. Neurosurg Focus 24:E15.
4. Hess DC and CV Borlongan. (2008). Stem cells and neurological diseases. Cell Prolif 41(Suppl 1):94-114.
5. Yasuhara T, CV Borlongan and I Date. (2006). Ex vivo gene therapy: transplantation of neurotrophic factor-secreting cells for cerebral ischemia. Front Biosci 11:760-775.
6. Bang OY, JS Lee, PH Lee and G Lee. (2005). Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol 57:874-882.
7. Su L, J Xu, BX Ji, SG Wan, CY Lu, HQ Dong, YY Yu and DP Lu. (2006). Autologous peripheral blood stem cell transplantation for severe multiple sclerosis. Int J Hematol 84:276-281.
8. Burt RK, Y Loh, B Cohen, D Stefosky, R Balabanov, G Katsamakis, Y Oyama, EJ Russell, J Stern, P Muraro, J Rose, A Testori, J Bucha, B Jovanovic, F Milanetti, J Storek, JC Voltarelli and WH Burns. (2009). Autologous non-myeloablative haemopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: a phase I/II study. Lancet Neurol 8:244-253.
9. Appel SH, JI Engelhardt, JS Henkel, L Siklos, DR Beers, AA Yen, EP Simpson, Y Luo, G Carrum, HE Heslop, MK Brenner and U Popat. (2008). Hematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosis. Neurology 71:1326-1334.
10. Lee PH, JW Kim, OY Bang, YH Ahn, IS Joo and K Huh. (2008). Autologous mesenchymal stem cell therapy delays the progression of neurological deficits in patients with multiple system atrophy. Clin Pharmacol Ther 83:723-730.
11. Sykova E, A Homola, R Mazanec, H Lachmann, SL Konradova, P Kobylka, R Padr, J Neuwirth, V Komrska, V Vavra, J Stulik and M Bojar. (2006). Autologous bone marrow transplantation in patients with subacute and chronic spinal cord injury. Cell Transplant 15:675-687.
12. Xu J, BX Ji, L Su, HQ Dong, XJ Sun and CY Liu. (2006). Clinical outcomes after autologous haematopoietic stem cell transplantation in patients with progressive multiple sclerosis. Chin Med J (Engl) 119:1851-1855.
13. Christie B. (2009). Study on stem cells for stroke patients to start in Scotland later in 2009. BMJ 338:b245.
14. Janowski M, E Gornicka-Pawlak, H Kozlowska, K Domanska- Janik, J Gielecki and B Lukomska. (2008). Structural and functional characteristic of a model for deep-seated lacunar infarct in rats. J Neurol Sci 273:40-48.
15. Smith ML and GV Glass. (1977). Meta-analysis of psychotherapy outcome studies. Am Psychol 32:752-760.
16. DerSimonian R and N Laird. (1986). Meta-analysis in clinical trials. Control Clin Trials 7:177-188.
17. Freedman LS and CK Clifford. (1994). Meta-analysis of animal experiments: elucidating relationships between dietary fat and mammary tumor development in rodents. Adv Exp Med Biol 364:93-100.
18. Bouzom F, C Laveille, H Merdjan and R Jochemsen. (2000). Use of nonlinear mixed effect modeling for the meta-analysis of preclinical pharmacokinetic data: application to S 20342 in the rat. J Pharm Sci 89:603-613.
19. Minnerup J, J Heidrich, J Wellmann, A Rogalewski, A Schneider and WR Schabitz. (2008). Meta-analysis of the efficacy of granulocyte-colony stimulating factor in animal models of focal cerebral ischemia. Stroke 39:1855-1861.
20. Wheble PC, ES Sena and MR Macleod. (2008). A systematic review and meta-analysis of the efficacy of piracetam and piracetam- like compounds in experimental stroke. Cerebrovasc Dis 25:5-11.
21. van der Worp HB, ES Sena, GA Donnan, DW Howells and MR Macleod. (2007). Hypothermia in animal models of acute ischaemic stroke: a systematic review and meta-analysis. Brain 130:3063-3074.
22. Sena E, P Wheble, P Sandercock and M Macleod. (2007). Systematic review and meta-analysis of the efficacy of tirilazad in experimental stroke. Stroke 38:388-394. (Pubitemid 46184311)
23. Willmot M, C Gibson, L Gray, S Murphy and P Bath. (2005). Nitric oxide synthase inhibitors in experimental ischemic stroke and their effects on infarct size and cerebral blood flow: a systematic review. Free Radic Biol Med 39:412-425. (Pubitemid 40916222)
24. Willmot M, L Gray, C Gibson, S Murphy and PM Bath. (2005). A systematic review of nitric oxide donors and l-arginine in experimental stroke; effects on infarct size and cerebral blood flow. Nitric Oxide 12:141-149. (Pubitemid 40432134)
25. Macleod MR, T O'Collins, LL Horky, DW Howells and GA Donnan. (2005). Systematic review and metaanalysis of the effi- cacy of FK506 in experimental stroke. J Cereb Blood Flow Metab 25:713-721. (Pubitemid 40705606)
26. Macleod MR, T O'Collins, LL Horky, DW Howells and GA Donnan. (2005). Systematic review and meta-analysis of the effi- cacy of melatonin in experimental stroke. J Pineal Res 38:35-41. (Pubitemid 40139308)
27. Glover CH, M Marin, CJ Eaves, CD Helgason, JM Piret and J Bryan. (2006). Meta-analysis of differentiating mouse embryonic stem cell gene expression kinetics reveals early change of a small gene set. PLoS Comput Biol 2:e158.
28. Martin-Rendon E, S Brunskill, C Doree, C Hyde, S Watt, A Mathur and S Stanworth. (2008). Stem cell treatment for acute myocardial infarction. Cochrane Database Syst Rev:CD006536.
29. Zhang SN, AJ Sun, JB Ge, K Yao, ZY Huang, KQ Wang and YZ Zou. (2008). Intracoronary autologous bone marrow stem cells transfer for patients with acute myocardial infarction: a meta-analysis of randomised controlled trials. Int J Cardiol 136:178-185.
30. Lipinski MJ, GG Biondi-Zoccai, A Abbate, R Khianey, I Sheiban, J Bartunek, M Vanderheyden, HS Kim, HJ Kang, BE Strauer and GW Vetrovec. (2007). Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. J Am Coll Cardiol 50:1761-1767.
31. Abdel-Latif A, R Bolli, IM Tleyjeh, VM Montori, EC Perin, CA Hornung, EK Zuba-Surma, M Al-Mallah and B Dawn. (2007). Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 167:989-997.
32. Kang S, YJ Yang, CJ Li and RL Gao. (2008). Effects of intracoronary autologous bone marrow cells on left ventricular function in acute myocardial infarction: a systematic review and metaanalysis for randomized controlled trials. Coron Artery Dis 19:327-335.
33. Macleod MR, T O'Collins, DW Howells and GA Donnan. (2004). Pooling of animal experimental data reveals infl uence of study design and publication bias. Stroke 35:1203-1208.
34. Hedges LV. (1984). Research synthesis: the state of the art. Int J Aging Hum Dev 19:85-93.
35. Begg CB and M Mazumdar. (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088-1101.
36. Egger M, G Davey Smith, M Schneider and C Minder. (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634.
37. Duval S and R Tweedie. (2000). Trim and fill: A simple funnelplot- based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56:455-463.
38. Bax L, LM Yu, N Ikeda, H Tsuruta and KG Moons. (2006). Development and validation of MIX: comprehensive free software for meta-analysis of causal research data. BMC Med Res Methodol 6:50.
39. Higgins JP, SG Thompson, JJ Deeks and DG Altman. (2003). Measuring inconsistency in meta-analyses. BMJ 327:557-560.
40. Higgins JP and SG Thompson. (2002). Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539-1558.
41. Xu H, RW Platt, ZC Luo, S Wei and WD Fraser. (2008). Exploring heterogeneity in meta-analyses: needs, resources and challenges. Paediatr Perinat Epidemiol 22(Suppl 1):18-28.
42. Thompson SG and JP Higgins. (2002). How should meta-regression analyses be undertaken and interpreted? Stat Med 21:1559-1573.
43. Thompson SG and JP Higgins. (2005). Treating individuals 4: can meta-analysis help target interventions at individuals most likely to benefit? Lancet 365:341-346.
44. Robenshtok E, A Gafter-Gvili, E Goldberg, M Weinberger, M Yeshurun, L Leibovici and M Paul. (2007). Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis. J Clin Oncol 25:5471-5489.